The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.

Latest News

Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS

February 17th 2025

In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.

Philips to Unveil AI-Enabled Ultrasound Updates at ECR
Philips to Unveil AI-Enabled Ultrasound Updates at ECR

February 14th 2025

Forecasting Supply and Demand in Radiology in 2055
Forecasting Supply and Demand in Radiology in 2055

February 13th 2025

Breast MRI and Ultrasound Findings Linked to Elevated Risk of Axillary Residual Disease After Neoadjuvant Therapy
Breast MRI and Ultrasound Findings Linked to Elevated Risk of Axillary Residual Disease After Neoadjuvant Therapy

February 10th 2025

Ultrasound Molecular Agent Gets FDA Fast Track Designation for Active Bowel Inflammation with Crohn’s Disease
Ultrasound Molecular Agent Gets FDA Fast Track Designation for Active Bowel Inflammation with Crohn’s Disease

February 7th 2025

Video Interviews
Latest CME Events & Activities

2025 GU Satellite Symposia in San Francisco

February 13-14, 2025

Register Now!

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

More News

© 2025 MJH Life Sciences

All rights reserved.